news release
- company news
in november 2008, c&o participated in the cefditoren licensing meeting organized by meiji, a leading food and drug company in japan, held in tokyo, japan. c&o has been meiji’s designated distributor since january 2008 for the sale of its new generation cephalosporin, meiact, in china.
address5/f, jihao building, 1086 shennan east road, luohu district, shenzhen
adverse drug reactions / event feedback hotline025-6816 1304
adverse drug reactions / event feedback mailgvp@changao.com
official wechat account mobile page